Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNYSE:HIMSNASDAQ:OPCHNASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$50.25+0.1%$45.41$20.14▼$53.42$6.22B1.442.16 million shs956,932 shsHIMSHims & Hers Health$47.92+1.0%$51.83$13.47▼$72.98$10.62B2.0223.39 million shs17.39 million shsOPCHOption Care Health$30.07-3.1%$32.02$21.39▼$35.53$5.08B0.731.87 million shs668,228 shsWGSGeneDx$91.61+2.0%$73.74$25.32▼$117.75$2.56B2.01816,175 shs328,245 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health-1.05%+0.56%+19.19%+19.42%+73.81%HIMSHims & Hers Health-0.88%+14.61%-16.25%+69.56%+123.82%OPCHOption Care Health-2.88%-2.39%-2.61%-11.19%+12.67%WGSGeneDx-0.55%+0.97%+21.13%+12.08%+223.45%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health3.7461 of 5 stars2.51.00.04.33.32.50.6HIMSHims & Hers Health2.2014 of 5 stars2.02.00.00.01.83.31.9OPCHOption Care Health4.3475 of 5 stars2.44.00.04.22.51.71.9WGSGeneDx2.2214 of 5 stars1.42.00.00.01.95.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.00Buy$53.766.99% UpsideHIMSHims & Hers Health 1.92Reduce$39.58-17.39% DownsideOPCHOption Care Health 2.88Moderate Buy$35.5018.06% UpsideWGSGeneDx 2.75Moderate Buy$90.13-1.62% DownsideCurrent Analyst Ratings BreakdownLatest WGS, HIMS, OPCH, and GH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/30/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$88.00 ➝ $115.006/24/2025HIMSHims & Hers HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$45.006/23/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell6/23/2025HIMSHims & Hers HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$30.006/23/2025HIMSHims & Hers HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingUnderperform ➝ Underperform6/23/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold6/18/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$36.006/13/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$60.00 ➝ $65.006/11/2025HIMSHims & Hers HealthMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Equal Weight$40.006/4/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$61.00 ➝ $65.005/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.00(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$739.02M8.42N/AN/A($1.13) per share-44.47HIMSHims & Hers Health$1.48B7.26$0.36 per share134.77$2.16 per share22.18OPCHOption Care Health$5.00B0.99$1.59 per share18.86$8.25 per share3.64WGSGeneDx$305.45M8.56$1.04 per share87.75$8.75 per share10.47Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$436.37M-$3.39N/AN/AN/A-53.82%N/A-26.77%8/6/2025 (Estimated)HIMSHims & Hers Health$126.04M$0.6969.4492.141.749.24%22.75%15.51%8/4/2025 (Estimated)OPCHOption Care Health$211.82M$1.2424.2523.871.874.12%16.90%7.00%7/30/2025 (Estimated)WGSGeneDx-$52.29M-$1.41N/A43.83N/A-11.69%10.17%5.51%7/29/2025 (Estimated)Latest WGS, HIMS, OPCH, and GH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/30/2025Q2 2025OPCHOption Care Health$0.40N/AN/AN/A$1.35 billionN/A7/29/2025Q2 2025WGSGeneDx$0.09N/AN/AN/A$86.00 millionN/A5/5/2025Q1 2025HIMSHims & Hers Health$0.12$0.20+$0.08$0.20$535.21 million$586.01 million4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A4.113.76HIMSHims & Hers HealthN/A1.591.32OPCHOption Care Health0.821.541.02WGSGeneDx0.203.253.07Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipGHGuardant Health6.10%HIMSHims & Hers Health13.71%OPCHOption Care Health0.64%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health2,021123.89 million116.33 millionNot OptionableHIMSHims & Hers Health1,637223.83 million193.15 millionOptionableOPCHOption Care Health8,088163.75 million162.70 millionOptionableWGSGeneDx1,20028.53 million20.09 millionOptionableWGS, HIMS, OPCH, and GH HeadlinesRecent News About These CompaniesGuggenheim Raises GeneDx (WGS) Price Target, Maintaining a Buy Rating5 hours ago | msn.comKevin Feeley Sells 1,344 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) StockJuly 3 at 2:50 PM | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $878,207.58 in StockJuly 3 at 2:50 PM | marketbeat.comAllspring Global Investments Holdings LLC Has $16.10 Million Stake in GeneDx Holdings Corp. (NASDAQ:WGS)July 3 at 4:23 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJuly 2 at 5:54 PM | globenewswire.comGeneDx (NASDAQ:WGS) Price Target Raised to $115.00 at GuggenheimJuly 2 at 2:17 AM | americanbankingnews.comWhy These Healthcare Stocks Are Suddenly Exploding in ValueJuly 1 at 12:04 AM | investing.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | MorningstarJune 30 at 8:13 PM | morningstar.comMExpert Outlook: GeneDx Holdings Through The Eyes Of 4 AnalystsJune 30 at 8:13 PM | benzinga.comBiotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains (WGS)...June 30 at 2:21 PM | marketbeat.comGuggenheim Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) StockJune 30 at 9:18 AM | marketbeat.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...June 29, 2025 | gurufocus.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 29, 2025 | globenewswire.comLisanti Capital Growth LLC Cuts Holdings in GeneDx Holdings Corp. (NASDAQ:WGS)June 29, 2025 | marketbeat.comGeneDx (WGS) Stock Gains After AAP Endorses Russell 1000June 28, 2025 | kalkinemedia.comKWhy GeneDX Stock Surged Higher This WeekJune 27, 2025 | finance.yahoo.comGeneDx Holdings Corp.'s (NASDAQ:WGS) Profit OutlookJune 26, 2025 | uk.finance.yahoo.comChung Wu Investment Group LLC Makes New $270,000 Investment in GeneDx Holdings Corp. (NASDAQ:WGS)June 26, 2025 | marketbeat.comBrokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) Price Target at $86.75June 26, 2025 | americanbankingnews.comWGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your RightsJune 25, 2025 | globenewswire.comInsiders Invested Millions in these Five Rebounding StocksJune 25, 2025 | 247wallst.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonHims & Hers Stock: Buy the Dip or Wait It Out?By Gabriel Osorio-Mazilli | June 5, 2025View Hims & Hers Stock: Buy the Dip or Wait It Out?Why Hims & Hers Stock Could Be a Multi-Bagger in the MakingBy Gabriel Osorio-Mazilli | June 24, 2025View Why Hims & Hers Stock Could Be a Multi-Bagger in the MakingWhy Hims & Hers Is a Buy Below $35 After Its 16% PullbackBy Gabriel Osorio-Mazilli | July 3, 2025View Why Hims & Hers Is a Buy Below $35 After Its 16% PullbackBiotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big GainsBy Nathan Reiff | June 30, 2025View Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big GainsWGS, HIMS, OPCH, and GH Company DescriptionsGuardant Health NASDAQ:GH$50.25 +0.07 (+0.14%) Closing price 02:58 PM EasternExtended Trading$50.50 +0.25 (+0.50%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$47.92 +0.46 (+0.96%) Closing price 03:58 PM EasternExtended Trading$47.82 -0.09 (-0.20%) As of 05:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$30.07 -0.96 (-3.09%) As of 02:33 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.GeneDx NASDAQ:WGS$91.61 +1.82 (+2.03%) Closing price 01:00 PM EasternExtended Trading$90.65 -0.96 (-1.05%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Nike's Stock Just Got an Upgrade: Is a Real Comeback Brewing? Why Hims & Hers Is a Buy Below $35 After Its 16% Pullback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
